跳至主要内容
临床试验/NCT01857076
NCT01857076已完成不适用

Surgical Treatment in Diabetic Patients With Grade 1 Obesity

Hospital Sirio-Libanes2 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2013年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
75
试验地点
2
主要终点
Diabetes remission evaluated by patients glycemic rates

研究概览

简要总结

There will be a randomized clinical trial, non-blind, 3-arm treatment (medical, surgical, gastric bypass and ileal transposition surgery with and sleeve), which will be conducted in a single center - S.B.S. Hospital Sirio Libanês, including 75 research subjects with type 2 diabetes mellitus and obesity class I. In order to compare the effect of weight loss on glycemic control among medical and surgical groups, and after 2 years of follow up, the results of efficacy, safety and maintenance will be compared between the three groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Man or woman with Type 2 diabetes mellitus (DM) aged between 25 and 65 years, with time since diagnosis of diabetes less than 10 years.
  • Grade I obesity (BMI between 30-35)
  • Inadequate glycemic control with HbA1c between 7.0 to 9.5% at baseline, in the presence of drug treatment for diabetes in the last year.
  • Reserve pancreatic C-peptide> 1.0 at baseline.
  • Overweight stable defined as BMI> 30 in the last two years.

排除标准

  • History ketoacidosis, diabetes mellitus type 1, diabetes followed by pancreatitis.
  • Repetition of measurements (ie, 2 or more within 1 week) fasting plasma glucose(FPG) > 240 mg / dL during the pre-treatment.
  • History of Severe Proliferative Diabetic Retinopathy.
  • Autonomic neuropathy.
  • Loss or gain significant weight within the last 12 weeks (range, 5% body weight)
  • Renal insufficiency
  • History of renal disease treated with immunosuppressive therapy, history of dialysis or kidney transplantation.
  • Presence of other renal diseases (eg nephrotic syndrome, glomerulonephritis)
  • Acute myocardial infarction, unstable angina (NYHA class III-IV), revascularization or stroke within the previous 3 months of the initial visit.
  • Uncontrolled hypertension defined as diastolic blood pressure> 100mm/Hg and diastolic blood pressure> 160mm/Hg at the initial visit.
  • History of Hepatitis B or Hepatitis C.
  • Criteria for Hepatic insufficiency defined as Child B and C liver disease clinically active and aspartate aminotransferase (AST) and alanine aminotransferase (ALT) above 3 times the upper limit of normal.
  • History of prior bariatric surgery.
  • Inflammatory Bowel Disease.
  • History neoplasm within the last 5 years (except for squamous cell carcinoma and basal skin and cervical carcinoma in situ)
  • Clinically important hematologic disorder (symptomatic anemia, bone marrow proliferative disorders, thrombocytopenia, ..)
  • History antibody positive human immunodeficiency virus (HIV)
  • Surgery with general anesthesia within 12 weeks prior to the initial visit or incomplete recovery from prior surgery.
  • History of drug or alcohol abuse within 3 years before the initial visit.
  • Pregnancy or breastfeeding or planning pregnancy in the next two years.

结局指标

主要结局

Diabetes remission evaluated by patients glycemic rates

时间窗: In 2 years

Comparison of diabetes remission between the two surgical modalities.

Glycemic blood rates

时间窗: In 2 years

Comparison of efficacy and safety in glycemic control between the medical and surgical treatment.

次要结局

  • Quality of life evaluation(In 2 years)
  • Number of Late Adverse Events(In 2 years)
  • Weight loss(In 2 years.)
  • Decrease in blood lipid(In 2 years)
  • Number of Early Adverse Events(In 2 years)
  • Number os Nutricional Complications(In 2 years)

研究者

发起方
Hospital Sirio-Libanes
申办方类型
Other
责任方
Principal Investigator
主要研究者

Cláudia Cozer

Md

Hospital Sirio-Libanes

研究点 (2)

Loading locations...

相似试验